F-group (family)
109.4.1.18 PPTA
Ligands and drugs
278
Member domains
167
with ligand contacts (≤ 4 Å)
60.1% of members
159
with DrugDomain annotations
57.2% of members
113
with a DrugBank compound
40.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 109.4.1.18 belongs to X-group 109 Repetitive alpha hairpins, which binds 9.1 ligand superclasses per 20 proteins, broader than 82% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB07780 | FPP | Farnesyl diphosphate | 40 |
| DB08180 | MGM | 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE | 37 |
| DB07771 | FII | [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID | 9 |
| DB07227 | 778 | L-778123 | 7 |
| DB07895 | HFP | ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID | 7 |
| DB04960 | JAN | Tipifarnib | 2 |
| DB06448 | 336 | Lonafarnib | 2 |
| DB06953 | 2C5 | 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE | 2 |
| DB07216 | 736 | (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE | 2 |
| DB07841 | — | Geranylgeranyl diphosphate | 2 |
| DB01785 | DMA | Dimethylallyl Diphosphate | 1 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 1 |
| DB04160 | PPV | Pyrophosphoric acid | 1 |
| DB04464 | — | N-Formylmethionine | 1 |
| DB08674 | U49 | (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE | 1 |
| DB08676 | U66 | (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE | 1 |
| DB12234 | BMV | BMS-214662 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FPP | FARNESYL DIPHOSPHATE | 41 |
| MGM | 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE | 36 |
| CL | CHLORIDE ION | 17 |
| GRG | GERANYLGERANYL DIPHOSPHATE | 17 |
| FII | [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID | 12 |
| 3FX | (2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid | 11 |
| 778 | 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE | 8 |
| HFP | ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID | 6 |
| FAR | FARNESYL | 5 |
| ZNmetal | ZINC ION | 5 |
| MGmetal | MAGNESIUM ION | 4 |
| 3CX | (2S)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid | 3 |
| DPO | DIPHOSPHATE | 3 |
| 3PZ | (3R)-3-benzyl-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile | 2 |
| 60I | [4-[[3-(2,2-dimethylpropyl)-1~{H}-benzimidazol-2-yl]methyl]piperazin-1-yl]-(1,3,5-trimethylpyrazol-4-yl)methanone | 2 |
| 7TP | 5-{(3R)-3-(4-hydroxybenzyl)-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-7-yl}furan-2-carbaldehyde | 2 |
| 7TQ | 4-({(3R)-7-cyano-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl}methyl)phenyl benzylcarbamate | 2 |
| ACE | ACETYL GROUP | 2 |
| ED5 | tert-butyl 4-({(2-{(4-cyanophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino}ethyl)[(2-methylphenyl)sulfonyl]amino}methyl)piperidine-1-carboxylate | 2 |
| GBO | (2E,6E)-3,7-dimethyl-8-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)octa-2,6-dien-1-yl trihydrogen diphosphate | 2 |